APA (7th ed.) Citation

G, A., TT, X., CS, P., AQ, L., L, Y., D, W., . . . J, L. (2022). QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway. Frontiers in pharmacology, 13, 918335. https://doi.org/10.3389/fphar.2022.918335

Chicago Style (17th ed.) Citation

G, Anwaier, et al. "QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway." Frontiers in Pharmacology 13 (2022): 918335. https://doi.org/10.3389/fphar.2022.918335.

MLA (9th ed.) Citation

G, Anwaier, et al. "QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway." Frontiers in Pharmacology, vol. 13, 2022, p. 918335, https://doi.org/10.3389/fphar.2022.918335.